Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tikkanen

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Transplantation|January 25, 2005
Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferationAntti I Nykänen, Rainer Krebs, Jussi M Tikkanen, et al.
Transplantation|February 18, 2003
Platelet-derived growth factor receptor inhibition reduces allograft arteriosclerosis of heart and aorta in cholesterol-fed rabbitsRoope K Sihvola, Jussi M Tikkanen, Rainer Krebs, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|September 2, 2016
Comparison of amniotic fluid matrix metalloproteinase-8 and cathelicidin in the diagnosis of intra-amniotic infectionT Myntti, L Rahkonen, A Pätäri-Sampo, et al.
American Journal of Respiratory and Critical Care Medicine|March 22, 2005
Dual role of vascular endothelial growth factor in experimental obliterative bronchiolitisRainer Krebs, Jussi M Tikkanen, Antti I Nykänen, et al.
Annals of Medicine|June 9, 2004
Role of angiogenic growth factors in transplant coronary artery diseaseKarl B Lemström, Antti I Nykänen, Jussi M Tikkanen, et al.
The American Journal of Pathology|September 11, 2012
Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitisRainer Krebs, Jussi M Tikkanen, Jussi O Ropponen, et al.
Clinical Transplantation|July 3, 2026
Incidence and Impact of RAS-Like Opacities During Preserved Lung Function After Lung TransplantationLaura H Peräkylä, Antti I Nykänen, Risto I Kesävuori, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 15, 2020
Extending cytomegalovirus prophylaxis in high-risk (D+/R-) lung transplant recipients from 6 to 9 months reduces cytomegalovirus disease: A retrospective studySabina Herrera, Basha Khan, Lianne G Singer, et al.
European Journal of Biochemistry|December 15, 1996
Exploring the substrate specificities of alpha-2,6- and alpha-2,3-sialyltransferases using synthetic acceptor analoguesJ A Van Dorst, J M Tikkanen, C H Krezdorn, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 31, 2018
Identification of risk epitope mismatches associated with de novo donor-specific HLA antibody development in cardiothoracic transplantationJ A McCaughan, R K Battle, S K S Singh, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Transplantation|January 25, 2005
Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferationAntti I Nykänen, Rainer Krebs, Jussi M Tikkanen, et al.
Transplantation|February 18, 2003
Platelet-derived growth factor receptor inhibition reduces allograft arteriosclerosis of heart and aorta in cholesterol-fed rabbitsRoope K Sihvola, Jussi M Tikkanen, Rainer Krebs, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|September 2, 2016
Comparison of amniotic fluid matrix metalloproteinase-8 and cathelicidin in the diagnosis of intra-amniotic infectionT Myntti, L Rahkonen, A Pätäri-Sampo, et al.
American Journal of Respiratory and Critical Care Medicine|March 22, 2005
Dual role of vascular endothelial growth factor in experimental obliterative bronchiolitisRainer Krebs, Jussi M Tikkanen, Antti I Nykänen, et al.
Annals of Medicine|June 9, 2004
Role of angiogenic growth factors in transplant coronary artery diseaseKarl B Lemström, Antti I Nykänen, Jussi M Tikkanen, et al.
The American Journal of Pathology|September 11, 2012
Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitisRainer Krebs, Jussi M Tikkanen, Jussi O Ropponen, et al.
Clinical Transplantation|July 3, 2026
Incidence and Impact of RAS-Like Opacities During Preserved Lung Function After Lung TransplantationLaura H Peräkylä, Antti I Nykänen, Risto I Kesävuori, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 15, 2020
Extending cytomegalovirus prophylaxis in high-risk (D+/R-) lung transplant recipients from 6 to 9 months reduces cytomegalovirus disease: A retrospective studySabina Herrera, Basha Khan, Lianne G Singer, et al.
European Journal of Biochemistry|December 15, 1996
Exploring the substrate specificities of alpha-2,6- and alpha-2,3-sialyltransferases using synthetic acceptor analoguesJ A Van Dorst, J M Tikkanen, C H Krezdorn, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 31, 2018
Identification of risk epitope mismatches associated with de novo donor-specific HLA antibody development in cardiothoracic transplantationJ A McCaughan, R K Battle, S K S Singh, et al.
Pageof 7